查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067634

口服固體製劑契約製造市場規模、佔有率和趨勢分析報告：按產品、作用機制、最終用途、地區和細分市場預測（2026-2033 年）

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules, Powders, Granules), By Mechanism (Controlled Release, Immediate Release), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

口服固體製劑契約製造概述

2025年全球口服固體製劑契約製造市場價值為102億美元，預計到2033年將達到212.5億美元，2026年至2033年的複合年成長率為9.2%。

推動市場成長的因素包括：製藥公司外包需求的增加、學名藥市場的擴張和專利到期、藥物輸送技術的不斷進步，以及對供應鏈韌性和本地化的日益重視。

為了降低資本支出和營運複雜性，製藥和生物製藥公司正大規模地將口服固體製劑(OSD) 的生產外包給合約研發生產機構 (CDMO)。此外，建立內部製劑研發、規模化生產和商業化生產能力需要對基礎設施、熟練人員和法規遵循進行大量投資。與 CDMO 合作使公司能夠專注於研發、臨床開發和商業化等核心業務。例如，2025 年 12 月，博拉製藥 (Bora Pharmaceutical) 和 Koalis Pharma 合作提供一體化的口服固體製劑研發和生產服務。此舉旨在透過將早期研發經驗與商業規模生產能力相結合，加速藥物開發並降低外包的複雜性。此外，外包還能提供專業技術、靈活的生產能力和全球法規的專業知識。這種趨勢不僅在缺乏生產能力的中小型生技公司中尤其明顯，在尋求最佳化成本、提高效率和縮短新藥上市時間的大型製藥企業中也是如此。

此外，受專利到期，學名藥市場擴張，進而提振了口服固體製劑（OSD）契約製造的需求。隨著專利到期，學名藥生產商力求快速開發並推出更具成本效益的替代產品，以搶佔市場佔有率。這就催生了對快速製劑開發、規模化生產和大規模生產能力的需求，而合約研發生產機構（CDMO）恰好能夠滿足這些需求。此外，醫療保健領域不斷上漲的醫療成本以及政府為推廣平價藥品而採取的舉措，也加速了學名藥在全球的普及。 CDMO透過提供具成本效益的生產解決方案、監管支援和規模化生產能力，協助市場成長，使學名藥生產商能夠在滿足高需求的同時，確保合規性和品質標準。

此外，藥物遞送技術的不斷進步是口服固體製劑（OSD）契約製造市場的主要驅動力之一。根據2026年3月的報告，高活性口服固體製劑（HPOSD）日益複雜，導致高活性、低劑量和特殊配方產品線不斷擴展，這些產品需要先進的密閉系統、專用設施和嚴格的安全規程。這些生產挑戰，加上不斷變化的監管要求和職業安全規範，使得許多製藥公司難以內部生產。因此，各公司正大規模地將生產外包給擁有先進密閉基礎設施、技術專長和成熟品質系統的合約研發生產機構（CDMO）。此外，對高效技術轉移、可擴展性和「一次成功」生產方法的日益成長的需求，也加速了企業對經驗豐富的合作夥伴的依賴。

此外，製藥公司越來越重視建立具有韌性和靈活性的供應鏈，尤其是在全球危機期間經歷供應鏈中斷之後。這促使企業加大對區域生產能力的投資，並與合約研發生產機構（CDMO）建立合作關係，以確保口服固體製劑的穩定供應。企業也採用多地點生產策略和近岸外包技術，以減少對單一地區的依賴，並降低與物流、地緣政治和監管變化相關的風險。憑藉其全球業務配置和綜合服務，CDMO 能夠很好地支援這些策略。它們能夠提供從研發到商業化生產的跨區域綜合解決方案，從而增強供應鏈的敏捷性和可靠性，使 CDMO 成為不斷發展的製藥行業中不可或缺的合作夥伴。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：口服固體製劑契約製造市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技
  • 定價模式分析
  • 關稅影響分析
  • 價值鏈分析
  • 市場分析工具

第4章：口服固體製劑契約製造市場：依產品類型分類的估算與趨勢分析

  • 口服固體製劑契約製造市場：基於產品的波動分析
  • 口服固體製劑契約製造市場：按產品分類，估算和預測（2021-2033 年）
  • 藥片
  • 膠囊
  • 粉末
  • 顆粒
  • 其他

第5章：口服固體製劑契約製造市場：依作用機制分類的估算與趨勢分析

  • 口服固體製劑契約製造市場：依作用機制分析波動狀況
  • 口服固體製劑契約製造市場：依作用機制分類的估算與預測（2021-2033 年）
  • 即時發布
  • 延遲釋放
  • 控釋

第6章：口服固體製劑契約製造市場：依最終用途分類的估算與趨勢分析

  • 口服固體製劑契約製造市場：依最終用途分類的波動分析
  • 口服固體製劑契約製造市場：依最終用途分類的估算與預測（2021-2033 年）
  • 大公司
  • 中型企業/中小企業
  • 其他

第7章：口服固體製劑契約製造市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 阿曼
    • 卡達

第8章 競爭情勢

  • 主要公司分類
    • 主要市場參與企業
    • 參與企業新興市場
  • 2025年市佔率及估值分析（熱圖分析）
  • 公司簡介
    • Catalent Inc.
    • Lonza
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Siegfried Holding AG
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing
    • Next Pharma AB
Product Code: GVR-4-68039-948-4

Oral Solid Dosage Contract Manufacturing Market Summary

The global oral solid dosage contract manufacturing market size was valued at USD 10.20 billion in 2025 and is projected to reach USD 21.25 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. The market is experiencing growth driven by rising demand for outsourcing by pharmaceutical companies, expansion of generic drug market and patent expirations, continuous advancements in drug delivery technologies and increasing focus on supply chain resilience and localization.

Pharmaceutical and biopharmaceutical companies are outsourcing oral solid dosage (OSD) manufacturing to contract development and manufacturing organizations (CDMOs) in large numbers to reduce capital expenditure and operational complexity. In addition, developing in-house capabilities for formulation, scale-up, and commercial production requires significant investment in infrastructure, skilled labor, and regulatory compliance. By partnering with CDMOs, companies can focus on core competencies such as research, clinical development, and commercialization. For instance, in December 2025, Bora Pharmaceuticals and Corealis Pharma partnered to provide integrated oral solid dosage development and manufacturing services, combining early-stage expertise with commercial-scale capabilities to accelerate drug development and reduce outsourcing complexity. In addition, outsourcing also provides access to specialized technologies, flexible production capacity, and global regulatory expertise. This trend is particularly strong among small and mid-sized biotech firms that lack manufacturing capabilities, as well as large pharmaceutical companies seeking to optimize costs, enhance efficiency, and accelerate time-to-market for new drug products.

In addition, growing generic drug market, driven by patent expirations of blockbuster drugs, is boosting demand for OSD contract manufacturing. As patents expire, generic drug manufacturers aim to quickly develop and launch cost-effective alternatives to capture market share. This creates a need for rapid formulation development, scale-up, and high-volume production capabilities, which CDMOs are well-equipped to provide. In addition, increasing healthcare cost pressures and government initiatives to promote affordable medicines are accelerating generic drug adoption globally. CDMOs offer cost-efficient manufacturing solutions, regulatory support, and scalability, enabling generic companies to meet high demand while maintaining compliance and quality standards, thus fueling growth in the market.

Furthermore, continuous advancements in drug delivery technologies is one of the key driver OSD contract manufacturing market. According to a report of March 2026, increasing complexity of highly potent oral solid dosage (HPOSD) drugs accelerates the growing pipeline of potent, low-dosage, and specialized formulations that requires advanced containment systems, specialized facilities, and strict safety protocols. These manufacturing challenges, combined with evolving regulatory expectations and occupational safety requirements, make in-house production difficult for many pharmaceutical companies. As a result, companies are outsourcing to CDMOs in large numbers with high-containment infrastructure, technical expertise, and proven quality systems. In addition, the need for efficient tech transfer, scalability, and "right-first-time" manufacturing approaches is accelerating reliance on experienced partners.

Moreover, pharmaceutical companies are placing greater emphasis on building resilient and flexible supply chains, particularly after disruptions experienced during global crises. This has led to increased investment in regional manufacturing capabilities and partnerships with CDMOs to ensure consistent supply of oral solid dosage drugs. In addition, companies are adopting multi-site manufacturing strategies and nearshoring approaches to reduce dependency on single regions and mitigate risks related to logistics, geopolitics, and regulatory changes. CDMOs with global footprints and integrated service offerings are well-positioned to support these strategies. Their ability to provide comprehensive solutions, from development to commercial manufacturing across multiple regions, enhances supply chain agility and reliability, making them critical partners in the evolving pharmaceutical landscape.

Global Oral Solid Dosage Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oral solid dosage contract manufacturing market based on product, mechanism, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tablets
  • Capsules
  • Powders
  • Granules
  • Others
  • Mechanism Outlook (Revenue, USD Million, 2021 - 2033)
  • Immediate Release
  • Delayed Release
  • Controlled Release
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Size Companies
  • Medium & Small Size Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Mechanism
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Oral Solid Dosage Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
      • 3.2.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
      • 3.2.1.4. Increasing Demand for One-Stop-Shop CMOs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Strict Approval Criteria by Regulatory Authorities
      • 3.2.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
      • 3.2.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
  • 3.3. Technology Landscape
    • 3.3.1. Manufacturing Technology
    • 3.3.2. Encapsulation Technology
    • 3.3.3. Coating Technology
    • 3.3.4. Packaging Technology
    • 3.3.5. Analytical Technology
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 4.1. Oral Solid Dosage Contract Manufacturing Market, By Product: Segment Dashboard
  • 4.2. Oral Solid Dosage Contract Manufacturing Market, By Product: Movement Analysis
  • 4.3. Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033
  • 4.4. Tablets
    • 4.4.1. Tablets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Capsules
    • 4.5.1. Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Powders
    • 4.6.1. Powders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Granules
    • 4.7.1. Granules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis

  • 5.1. Oral Solid Dosage Contract Manufacturing Market, By Mechanism: Segment Dashboard
  • 5.2. Oral Solid Dosage Contract Manufacturing Market, By Mechanism: Movement Analysis
  • 5.3. Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts, By Mechanism, 2021 - 2033
  • 5.4. Immediate Release
    • 5.4.1. Immediate Release Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Delayed Release
    • 5.5.1. Delayed Release Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Controlled Release
    • 5.6.1. Controlled Release Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Oral Solid Dosage Contract Manufacturing Market, By End Use: Segment Dashboard
  • 6.2. Oral Solid Dosage Contract Manufacturing Market, By End Use: Movement Analysis
  • 6.3. Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033
  • 6.4. Large Size Companies
    • 6.4.1. Large Size Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Medium & Small Size Companies
    • 6.5.1. Medium & Small Size Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2025 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Oman
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Qatar
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Catalent Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Lonza
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Aenova Group
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Boehringer Ingelheim International GmbH
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Jubilant Pharmova Limited
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Patheon Pharma Services
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Recipharm AB.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Corden Pharma International
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Siegfried Holding AG
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Piramal Pharma Solutions
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. AbbVie Contract Manufacturing
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Next Pharma AB
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 5 Global Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 Global Oral Solid Dosage Contract Manufacturing Market, by Region, 2021 - 2033 (USD Million)
  • Table 7 North America Oral Solid Dosage Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 9 North America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 10 North America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 12 U.S. Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 13 U.S. Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 15 Canada Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 16 Canada Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 Mexico Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 19 Mexico Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Oral Solid Dosage Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Europe Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 23 Europe Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 25 UK Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 26 UK Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 28 Germany Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 29 Germany Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 France Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 31 France Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 32 France Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 34 Italy Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 35 Italy Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 37 Spain Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 38 Spain Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39 Denmark Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 40 Denmark Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 41 Denmark Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Sweden Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Sweden Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 44 Sweden Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 46 Norway Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 47 Norway Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52 China Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 53 China Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 54 China Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55 Japan Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Japan Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 57 Japan Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58 India Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 India Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 60 India Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 62 Australia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 63 Australia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 64 South Korea Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 65 South Korea Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 66 South Korea Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 Thailand Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 68 Thailand Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 69 Thailand Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Oral Solid Dosage Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 72 Latin America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 73 Latin America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 75 Brazil Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 76 Brazil Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 78 Argentina Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 79 Argentina Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 85 South Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 86 South Africa Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 91 UAE Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 92 UAE Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Oman Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 97 Oman Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 98 Oman Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Qatar Oral Solid Dosage Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 100 Qatar Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 101 Qatar Oral Solid Dosage Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value-Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Oral Solid Dosage Contract Manufacturing Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Oral Solid Dosage Contract Manufacturing Market: Product Outlook and Key Takeaways
  • Fig. 20 Oral Solid Dosage Contract Manufacturing Market: Product Movement Analysis
  • Fig. 21 Tablets Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Capsules Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Powders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Granules Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Oral Solid Dosage Contract Manufacturing Market: Mechanism Outlook and Key Takeaways
  • Fig. 27 Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
  • Fig. 28 Immediate Release Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Delayed Release Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Controlled Release Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Oral Solid Dosage Contract Manufacturing Market: End Use Outlook and Key Takeaways
  • Fig. 32 Oral Solid Dosage Contract Manufacturing Market: End Use Movement Analysis
  • Fig. 33 Large Size Companies Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Medium & Small Size Companies Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 North America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Canada Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Mexico Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 UK Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 France Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Italy Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Spain Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Denmark outsourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Sweden outsourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Norway outsourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Japan Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 China Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 India Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Thailand Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Korea Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Australia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Brazil Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Argentina Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 MEA Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Africa Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Fig. Key country dynamics
  • Fig. 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 UAE Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Oman Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Qatar Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)